FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mizel, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizel, S. B.

The FASEB Journal, Vol 3, 2379-2388, Copyright © 1989 by The Federation of American Societies for Experimental Biology


REVIEWS

The interleukins

SB Mizel
Department of Microbiology and Immunology, Wake Forest University Medical Center, Winston-Salem, North Carolina 27103.

The interactions between immune and inflammatory cells are mediated in large part by proteins, termed interleukins (IL), that are able to promote cell growth, differentiation, and functional activation. Seven interleukins have been described; each has unique biological activities as well as some that overlap with the others. Macrophages, cells that play important roles in both immunity and inflammation, produce IL 1 and IL 6, whereas T cells produce IL 2-IL 6 and bone marrow stromal cells produce IL 7. IL 1 and IL 6 not only play important roles in immune cell function, but also stimulate a spectrum of inflammatory cell types and induce fever. The growth and differentiation of eosinophils is markedly enhanced by IL 5. IL 2 is a potent proliferative signal for T cells, natural killer cells, and lymphokine- activated killer cells. IL 1, IL 3, IL 4, and IL 7 enhance the development of a variety of hematopoietic precursors. IL 4-IL 6 also serve to enhance B cell proliferation and antibody production. The understanding of interleukin structure and function has led to new and important insights into the fundamental biology of immunity and inflammation.


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. van Minkelen, M. C.H. de Visser, J. J. Houwing-Duistermaat, H. L. Vos, R. M. Bertina, and F. R. Rosendaal
Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the Risk of Venous Thrombosis
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1486 - 1491.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H.-Y. Huang, Y. Wen, J. S. Kruessel, F. Raga, Y.-K. Soong, and M. L. Polan
Interleukin (IL)-1{beta} Regulation of IL-1{beta} and IL-1 Receptor Antagonist Expression in Cultured Human Endometrial Stromal Cells
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1387 - 1393.
[Abstract] [Full Text]


Home page
Am J EpidemiolHome page
D. F. Geffken, M. Cushman, G. L. Burke, J. F. Polak, P. A. Sakkinen, and R. P. Tracy
Association between Physical Activity and Markers of Inflammation in a Healthy Elderly Population
Am. J. Epidemiol., February 1, 2001; 153(3): 242 - 250.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Aung and B. S. Graham
IL-4 Diminishes Perforin-Mediated and Increases Fas Ligand-Mediated Cytotoxicity In Vivo
J. Immunol., April 1, 2000; 164(7): 3487 - 3493.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. B. McKay, H. Y. Irie, G. Hollander, J. L. M. F. Ferrara, T. B. Strom, Y. Li, and S. J. Burakoff
Antigen-Induced Unresponsiveness Results in Altered T Cell Signaling
J. Immunol., December 15, 1999; 163(12): 6455 - 6461.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Aung, Y.-W. Tang, and B. S. Graham
Interleukin-4 Diminishes CD8+ Respiratory Syncytial Virus-Specific Cytotoxic T-Lymphocyte Activity In Vivo
J. Virol., November 1, 1999; 73(11): 8944 - 8949.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E.-B. Haddad, J. Rousell, M. A. Lindsay, and P. J. Barnes
Synergy between Tumor Necrosis Factor alpha and Interleukin 1beta in Inducing Transcriptional Down-regulation of Muscarinic M2 Receptor Gene Expression. INVOLVEMENT OF PROTEIN KINASE A AND CERAMIDE PATHWAYS
J. Biol. Chem., December 20, 1996; 271(51): 32586 - 32592.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Liu, R. P. Hart, X.-J. Liu, W. Clevenger, R. A. Maki, and E. B. De Souza
Cloning and Characterization of an Alternatively Processed Human Type II Interleukin-1 Receptor mRNA
J. Biol. Chem., August 23, 1996; 271(34): 20965 - 20972.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by The Federation of American Societies for Experimental Biology.